CXCR3 and familial pancreatic carcinoma: reported that chemokines attracted by C-X-C Motif Chemokine Receptor 3 (CXCR3), which are also dependent on IFN, can be produced through STING activation, and it means that CXCR3 has a crucial role in the anti-tumor activity of STING agonist treatment in pancreatic cancer (92).